-
-
-
-
-
-
-
US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) announces Shingrix approved in US for prevention of shingles in immunocompromised adults
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) Says FDA Advisory Committee Votes Unanimously for Shingrix for Prevention of Shingles
-
-
-
-
-
13,123 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All